Novo Nordisk
NVO
NVO
525 hedge funds and large institutions have $11B invested in Novo Nordisk in 2015 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 183 increasing their positions, 187 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $11.2B → $11B (-$204M)
2% less repeat investments, than reductions
Existing positions increased: 183 | Existing positions reduced: 187
59% less call options, than puts
Call options by funds: $9.93M | Put options by funds: $24.5M
Holders
525
Holding in Top 10
32
Calls
$9.93M
Puts
$24.5M
Top Buyers
| 1 | +$287M | |
| 2 | +$96.3M | |
| 3 | +$60.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$25.8M |
Top Sellers
| 1 | -$88.8M | |
| 2 | -$82.1M | |
| 3 | -$49.7M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$34.9M |
| 5 |
Bank of New York Mellon
New York
|
-$30.9M |